IL23A and metabolic dysfunction-associated steatohepatitis: In our study, CHC-SF patients as well as NASH patients had significantly higher plasma levels of IL-17A in comparison with CHC-NSF and CG, while all three CLD groups had higher levels of IL-23 in comparison with CG.